###begin article-title 0
The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair
###end article-title 0
###begin p 1
Conceived and designed the experiments: DL MLT PG LS MF CV PR CM AB MC MPA. Performed the experiments: DL MLT PG MF GV CG PR SC AB MC. Analyzed the data: DL MLT PG LS MF GV CV PR AB MC MPA. Contributed reagents/materials/analysis tools: MLT LS PC CV CG UG ET PR SC CM. Wrote the paper: DL AB MC MPA.
###end p 1
###begin p 2
###xml 753 754 753 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1232 1239 1232 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1676 1677 1676 1677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1871 1879 1871 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1973 1974 1973 1974 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1211 1215 <span type="species:ncbi:10090">mice</span>
###xml 2495 2503 <span type="species:ncbi:9606">patients</span>
Deciphering the mechanisms regulating the generation of new neurons and new oligodendrocytes, the myelinating cells of the central nervous system, is of paramount importance to address new strategies to replace endogenous damaged cells in the adult brain and foster repair in neurodegenerative diseases. Upon brain injury, the extracellular concentrations of nucleotides and cysteinyl-leukotrienes (cysLTs), two families of endogenous signaling molecules, are markedly increased at the site of damage, suggesting that they may act as "danger signals" to alert responses to tissue damage and start repair. Here we show that, in brain telencephalon, GPR17, a recently deorphanized receptor for both uracil nucleotides and cysLTs (e.g., UDP-glucose and LTD4), is normally present on neurons and on a subset of parenchymal quiescent oligodendrocyte precursor cells. We also show that induction of brain injury using an established focal ischemia model in the rodent induces profound spatiotemporal-dependent changes of GPR17. In the lesioned area, we observed an early and transient up-regulation of GPR17 in neurons expressing the cellular stress marker heat shock protein 70. Magnetic Resonance Imaging in living mice showed that the in vivo pharmacological or biotechnological knock down of GPR17 markedly prevents brain infarct evolution, suggesting GPR17 as a mediator of neuronal death at this early ischemic stage. At later times after ischemia, GPR17 immuno-labeling appeared on microglia/macrophages infiltrating the lesioned area to indicate that GPR17 may also acts as a player in the remodeling of brain circuitries by microglia. At this later stage, parenchymal GPR17+ oligodendrocyte progenitors started proliferating in the peri-injured area, suggesting initiation of remyelination. To confirm a specific role for GPR17 in oligodendrocyte differentiation, the in vitro exposure of cortical pre-oligodendrocytes to the GPR17 endogenous ligands UDP-glucose and LTD4 promoted the expression of myelin basic protein, confirming progression toward mature oligodendrocytes. Thus, GPR17 may act as a "sensor" that is activated upon brain injury on several embryonically distinct cell types, and may play a key role in both inducing neuronal death inside the ischemic core and in orchestrating the local remodeling/repair response. Specifically, we suggest GPR17 as a novel target for therapeutic manipulation to foster repair of demyelinating wounds, the types of lesions that also occur in patients with multiple sclerosis.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 254 257 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Burnstock1">[1]</xref>
###xml 435 454 435 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,2,4,6,11,12,13,14</sub>
###xml 466 469 466 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Burnstock1">[1]</xref>
###xml 471 474 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Abbracchio1">[2]</xref>
###xml 693 696 693 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Burnstock1">[1]</xref>
###xml 698 701 698 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Abbracchio1">[2]</xref>
###xml 755 756 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 761 762 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 770 771 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 832 835 832 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Samuelsson1">[3]</xref>
###xml 879 882 879 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Drazen1">[4]</xref>
###xml 925 926 925 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 936 937 936 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 948 951 948 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Brink1">[5]</xref>
###xml 634 639 <span type="species:ncbi:9606">human</span>
Extracellular adenine (ATP, ADP), uracil (UTP, UDP) and sugar nucleotides (e.g., UDP-glucose and UDP-galactose) are universal and phylogenetically ancient signaling molecules involved in many biological processes, from embryogenesis to adult homeostasis [1]. Their actions on target cells are mediated by specific membrane receptors: the seven ligand-gated purinergic P2X channels and the eight G protein-coupled P2Y receptors (the P2Y1,2,4,6,11,12,13,14 receptors) [1], [2]. Owing to their involvement in the regulation of many physiological phenomena, dysfunctions of nucleotides and their receptors have been associated to various human diseases, including ischemic/inflammatory conditions [1], [2]. Instead, cysteinyl-leukotrienes (cysLTs, such as LTC4, LTD4 and LTE4) are inflammatory 5-lipoxygenase arachidonic acid mediators [3] with established roles in bronchial asthma [4] acting through the G protein-coupled CysLT1 and CysLT2 receptors [5].
###end p 4
###begin p 5
###xml 339 342 339 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Capra1">[6]</xref>
###xml 463 464 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 530 533 530 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ballerini1">[7]</xref>
###xml 787 790 787 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciceri1">[8]</xref>
###xml 1034 1037 1034 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Melani1">[9]</xref>
###xml 347 350 <span type="species:ncbi:10116">rat</span>
###xml 672 675 <span type="species:ncbi:10116">rat</span>
Recent data highlight the existence of a functional crosstalk between the nucleotide and the cysLT systems in orchestrating inflammatory responses in various disease conditions, including ischemic stroke. Both types of mediators accumulate at the sites of inflammation, and inflammatory cells often co-express both P2Y and CysLT receptors [6]. In rat microglia, the brain immune cells involved in the response to cerebral hypoxia and trauma, the activation of P2Y1 and CysLT receptors mediate co-release of nucleotides and cysLTs [7], which might, in turn, contribute to neuroinflammation and neurodegeneration. In the middle cerebral artery occlusion (MCAo) model in the rat, levels of cysLTs in the lesioned cortex were sharply increased 4 h after MCAo and rapidly declined afterwards [8]. In the same experimental model, extracellular concentrations of ATP were instead constantly elevated starting from 20 min after MCAo throughout a 220 min of microdialysis sampling, with a time course similar to that of excitatory amino acids [9]. Thus, at the site of brain injury, neurons and glia are exposed to high concentrations of both extracellular nucleotides and cysLTs, suggesting that these signaling molecules may act as "danger signals" to alert responses to tissue damage and start repair.
###end p 5
###begin p 6
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Blasius1">[10]</xref>
###xml 303 304 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 312 313 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 1139 1144 1139 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fetal</italic>
###xml 1149 1154 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adult</italic>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Maisel1">[12]</xref>
###xml 621 626 <span type="species:ncbi:9606">human</span>
###xml 654 657 <span type="species:ncbi:10116">rat</span>
###xml 802 805 <span type="species:ncbi:10116">rat</span>
###xml 1133 1138 <span type="species:ncbi:9606">human</span>
We have recently reported that GPR17, a previously orphan G protein-coupled receptor [10] (GPCR) at an intermediate phylogenetic position between P2Y and CysLT receptor families, is a new P2Y receptor specifically activated by both uracil nucleotides (UDP, UDP-glucose and UDP-galactose) and cysLTs (LTD4 and LTC4) [11]. Consistent with this hybrid pharmacology, activation of GPR17 by uracil nucleotides was counteracted by the P2Y receptor antagonists cangrelor and MRS2179, whereas its activation by cysLTs was antagonized by montelukast and pranlukast, two already marketed CysLT receptor blockers (ibidem). Both the human and the previously unknown rat receptor were found to be highly expressed in organs typically undergoing ischemic damage, i.e., brain, heart and kidney. Moreover, in the MCAo rat model, 48 hours after ischemia induction, GPR17-immunoreactivity was markedly increased in the ipsilateral cortex both within and at the borders of the ischemic infarct, suggesting a potential role in the evolution of ischemic damage. On the other hand, in a recent transcriptome study comparing the gene expression pattern of human fetal and adult neuroprogenitor cells (NPCs), GPR17 was identified as one of the three genes that were exclusively expressed in adult hippocampal NPCs [12], thus highlighting a potential role in brain repair. Thus, GPR17 may have a differential role in brain response to injury, depending upon whether the receptor is already constitutively expressed by the cell or is induced as a result of brain insult. Moreover, a differential role of GPR17 may also depend on specific phases of brain response after the insult (sequentially, death of irreversibly damaged cells, clearance of dead cells, remodeling and repair).
###end p 6
###begin p 7
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
On this basis, the present study has been specifically aimed at assessing the localization of GPR17 in cells of different lineages (neurons, glia and neural progenitor cells) of the intact mouse brain and its changes at different times after induction of focal cerebral ischemia in the MCAo model.
###end p 7
###begin p 8
We show that in the intact brain GPR17 is expressed by neurons and by a subset of adult quiescent parenchymal oligodendrocyte progenitors. Following ischemia, GPR17 is sequentially induced in neurons, microglia/macrophages and adult oligodendrocyte precursor cells, suggesting that it may act as a common regulatory gene mediating response to injury in embryonically-distinct cell types. This indicates GPR17 as a possible target for pharmacological intervention in neurodegeneration processes including cerebral ischemia and demyelinating diseases.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Cloning and characterization of mouse GPR17
###end title 10
###begin p 11
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 698 708 698 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003579.s001">Figure S1A</xref>
###xml 1073 1077 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 1333 1343 1333 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003579.s001">Figure S1B</xref>
###xml 1527 1531 1527 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 1752 1762 1752 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003579.s001">Figure S1C</xref>
###xml 1990 2000 1990 2000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003579.s001">Figure S1C</xref>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 122 126 <span type="species:ncbi:10090">MCAo</span>
###xml 222 228 <span type="species:ncbi:10090">murine</span>
###xml 268 273 <span type="species:ncbi:10090">Mouse</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 455 458 <span type="species:ncbi:10116">rat</span>
###xml 536 541 <span type="species:ncbi:10090">mouse</span>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
###xml 740 745 <span type="species:ncbi:10090">mouse</span>
###xml 856 862 <span type="species:ncbi:10090">murine</span>
###xml 934 939 <span type="species:ncbi:9606">human</span>
###xml 1053 1058 <span type="species:ncbi:9606">human</span>
###xml 1063 1066 <span type="species:ncbi:10116">rat</span>
###xml 1448 1454 <span type="species:ncbi:9986">rabbit</span>
###xml 1507 1512 <span type="species:ncbi:9606">human</span>
###xml 1517 1520 <span type="species:ncbi:10116">rat</span>
To study in detail the role of GPR17 in brain injury, the well established model of focal cerebral ischemia in the mouse (MCAo) was chosen. Thus, as a first step, we cloned and characterized the previously uncharacterized murine GPR17 ortholog (GenBank NM_001025381). Mouse GPR17, which is localized on chromosome 18, contains a 1020 base pairs open reading frame (ORF) that encodes for a putative 339 amino acid protein 90 and 98% identical to human and rat GPR17 [11]. Specific external primers were used to amplify cDNA from several mouse tissues. Specific PCR products of the expected mw (1022 bp) were obtained from mouse brain, kidney, heart and skeletal muscle, but not from liver and lung (Figure S1A). The 1022 bp PCR product from mouse brain cDNA was then cloned into a pcDNA3.1/V5-His-TOPO expression vector. The plasmid containing the positive murine GPR17 clone (pcDNA3.1-Gpr17m) was used to transiently transfect 1321N1 human astrocytoma cells, a cell line lacking endogenous P2Y receptors and already utilized for the characterization of human and rat GPR17 [11]. Expression of the transfected receptor was assessed by the appearance of a PCR product of the expected 1022 bp length in cells receiving pcDNA3.1-Gpr17m, whereas no expression of mGPR17 was found in cells transfected with the corresponding empty vector (Figure S1B). To confirm that the receptor transcript is indeed translated into the receptor protein, we utilized a rabbit anti-GPR17 polyclonal antibody that also recognizes human and rat GPR17 [11]. As expected, upon incubation with this antibody, 1321N1 cells transfected with pcDNA3.1-Gpr17m showed a specific immunoreactive signal which, instead, was not detected in cells receiving the corresponding empty vector (Figure S1C). To further confirm the specificity of these results, in the mGPR17-expressing cells, pre-adsorption of the anti-receptor antibody with the neutralizing peptide utilized for immunization completely abolished the GPR17 signal (Figure S1C).
###end p 11
###begin p 12
###xml 183 185 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 232 236 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Marteau1">[13]</xref>
###xml 326 328 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 414 418 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Marteau1">[13]</xref>
###xml 420 424 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Kotani1">[14]</xref>
###xml 426 430 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Fumagalli1">[15]</xref>
###xml 569 570 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 575 576 567 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 584 585 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 726 728 714 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 789 798 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g001">Figure 1A</xref>
###xml 846 847 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 852 853 834 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 862 863 844 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 957 959 939 941 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 991 992 971 972 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1015 1016 993 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1043 1044 1019 1020 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1046 1055 1022 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g001">Figure 1B</xref>
###xml 1130 1146 1106 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g001">Figure 1A and 1B</xref>
###xml 1216 1225 1192 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g001">Figure 1C</xref>
###xml 1409 1414 1381 1386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12/13</sub>
###xml 1487 1491 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 1574 1576 1542 1544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1723 1724 1685 1686 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1736 1738 1698 1700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1761 1770 1721 1730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g001">Figure 1D</xref>
###xml 1467 1472 <span type="species:ncbi:9606">human</span>
###xml 1477 1480 <span type="species:ncbi:10116">rat</span>
The pharmacological profile of mGPR17 was then assessed. Since stimulation of GPCRs results in increased binding of GTP to G proteins (which can, in turn, be quantified by measuring [35S]GTPgammaS binding to purified membranes; see [13]), GPR17 activation in the heterologous system was determined by testing the increase of [35S]GTPgammaS binding by exogenously-added agonists in membranes from transfected cells [13], [14], [15]. Full concentration-response curves with the uracil nucleotide UDP, the sugar nucleotides UDP-glucose and UDP-galactose and the cysLTs LTC4, LTD4 and LTE4 were performed. In GPR17-expressing cells, UDP, UDP-glucose and UDP-galactose concentration-dependently stimulated GTPgammaS binding with EC50 values of 55+/-6.2, 88+/-7.4 and 68+/-7.3 nM, respectively (Figure 1A). All tested leukotriene derivatives (i.e., LTC4, LTD4, and LTE4) were able to stimulate receptor-G protein coupling with a similar potency, with estimated EC50 values of 0.74+/-0.2 nM for LTC4, 0.63+/-0.1 nM for LTD4 and 0.31+/-0.09 nM for LTE4 (Figure 1B). None of these agonists, tested at the highest concentration utilized in Figure 1A and 1B, had any effect in cells transfected with the pcDNA3.1 empty vector (Figure 1C). The ability of some known purinergic and cysLT antagonists to counteract agonist-induced GTPgammaS binding stimulation in cells expressing mGPR17 was also assessed. Cangrelor, a P2Y12/13 antagonist, which displayed a high affinity towards human and rat GPR17 [11] concentration-dependently inhibited GTPgammaS binding stimulated by UDP with an IC50 value of 1.2+/-0.3 nM. In a similar way, the CysLT1 antagonist montelukast concentration-dependently inhibited GTPgammaS binding stimulated by LTD4, with an IC50 value of 61+/-4.6 nM (Figure 1D).
###end p 12
###begin title 13
###xml 61 63 61 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
Effect of purinergic and leukotriene ligands on mGPR17 with [35S]GTPgammaS binding.
###end title 13
###begin p 14
###xml 346 347 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 352 353 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 361 362 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 463 465 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 698 699 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 762 764 746 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
Membrane aliquots (10 microg), obtained from 1321N1 cells transfected with pcDNA3.1-Gpr17m (A,B), were incubated with the indicated concentrations of purinergic (A) or leukotriene (B) agonists. (C) Membranes from cells transfected with the pcDNA3.1 empty vector were incubated with UDP, UDP-glucose or UDP-galactose (all at 10 microM) or with LTD4, LTC4 and LTE4 (all at 50 nM), as indicated. (D) Effect of P2Y or CysLT receptor antagonist on agonist-stimulated [35S]GTPgammaS binding. Membranes from pcDNA3.1-Gpr17m transfected cells were pre-incubated for 10 min with graded montelukast (1 nM-1 microM) or Cangrelor (0.01 nM-100 nM) concentrations and then stimulated with 500 nM UDP or 50 nM LTD4, respectively. All data are expressed as percentage of basal [35S]GTPgammaS binding (set to 100%) and represent the mean+/-SEM of three different experiments each performed in duplicate.
###end p 14
###begin p 15
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 247 250 <span type="species:ncbi:10116">rat</span>
###xml 475 480 <span type="species:ncbi:10090">mouse</span>
###xml 541 546 <span type="species:ncbi:9606">human</span>
Globally, these data characterize the previously unknown mouse GPR17 receptor, demonstrate that this receptor is indeed expressed at high levels in various organs (including brain) and that, in a similar way to the already characterized human and rat receptors, this receptor can be dually activated by two distinct classes of endogenous ligands, uracil nucleotides and cysLTs, which are both released in great amounts in the injured brain. Moreover, they also show that the mouse receptor more closely resembles the response profile of the human receptor [11].
###end p 15
###begin title 16
In brain, GPR17 is normally expressed in neurons and in a subset of adult neural precursor cells
###end title 16
###begin p 17
###xml 491 500 491 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2A</xref>
###xml 553 554 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 635 644 635 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2B</xref>
###xml 656 665 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2C</xref>
###xml 815 816 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 826 846 826 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2D, 2D&#8242;, 2D&#8243;</xref>
###xml 969 978 968 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2E</xref>
###xml 994 1003 990 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2F</xref>
###xml 1116 1130 1112 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2A, 2A&#8242;</xref>
###xml 1152 1161 1148 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2F</xref>
###xml 1205 1214 1201 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2A</xref>
###xml 1285 1289 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Buffo1">[16]</xref>
###xml 1345 1346 1341 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1431 1435 1427 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Dawson1">[17]</xref>
###xml 1565 1566 1561 1562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1676 1685 1672 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2G</xref>
###xml 1747 1756 1743 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2G</xref>
###xml 1824 1833 1820 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2G</xref>
###xml 1926 1927 1922 1923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2141 2145 2137 2141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Dawson1">[17]</xref>
###xml 2190 2191 2186 2187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2362 2363 2356 2357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2418 2435 2412 2429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2H and 2H&#8242;</xref>
###xml 2463 2464 2455 2456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
We then utilized the specific anti-GPR17 antibody to determine the cellular localization of GPR17 in control mouse brain. Coronal sections taken at different brain levels were immuno-labeled with the anti-receptor antibody in parallel with markers of neuronal or glial cells. In the intact cerebral cortex, immunohistochemical studies with a high sensitivity amplification kit revealed GPR17 expression in two distinct types of cells. One cell type had neuronal morphology (see asterisks in Figure 2A): the neuronal nature of these GPR17-positive (GPR17+) cells was confirmed by co-staining with the neuronal specific markers SMI-311 (Figure 2B) and NeuN (Figure 2C). Higher magnification analysis of these cells suggested that, as expected for a GPCR, GPR17 was selectively expressed in the plasma-membrane of NeuN+ neurons (Figure 2D, 2D', 2D''). Conversely, no co-localization was found with cortical astrocytes, as shown by labeling with the specific markers GFAP (Figure 2E) and S100beta (Figure 2F). The other cell type expressing GPR17 displayed small cell bodies with fine radiating processes (see arrows in Figure 2A, 2A' inset, and arrows in Figure 2F). These cells were dispersed in both gray (Figure 2A) and white matter (not shown) and were reminiscent of precursor cells [16]. To investigate the nature of the highly branched GPR17+ cells, we performed staining for the pre-oligodendroglial specific proteoglycan NG2 [17]. Double-staining experiments revealed a heterogeneous population of ramified cells. In particular, 3 distinct phenotypes of GPR17+ ramified cells were found: a first cell type was characterized by exclusive expression of NG2 (arrowheads in Figure 2G), a second by exclusive expression of GPR17 (white arrows in Figure 2G) while a third cell type co-expressed both markers (blue arrows in Figure 2G and inset). Quantitative analysis of these cells showed that about 1/4 of the ramified GPR17+ cells also displayed NG2 staining. Co-expression with markers of pre-oligodendrocytes was further confirmed using an antibody against the transcription factor Olig2, a key regulator of oligodendrocyte development [17]. In this case, a much higher number of GPR17+ cells were also positive for Olig2. Quantitative fluorescence microscopy analysis of full hemisphere sections in 3 animals showed that 59.18+/-5.46% of the ramified GPR17+ cells indeed also co-expressed Olig2 in their nuclei (Figure 2H and 2H'; a mean of 680+/-52.2 GPR17+ cells were counted/animal; of these, 403+/-49.7 also positively stained for Olig2).
###end p 17
###begin title 18
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Cellular localization of GPR17 in the intact mouse brain.
###end title 18
###begin p 19
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 822 823 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1286 1287 1282 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1296 1297 1292 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Double fluorescence labeling of mouse brain coronal sections with anti-GPR17 antibody (red fluorescence) and markers for different cell lineages (green fluorescence). (A) In the intact cortex, GPR17 expression is detected in large round cells present at high density (examples are illustrated by asterisks) and in sparse ramified cells (arrows and A' inset). Virtually all GPR17+ large cell bodies display co-expression of the neuronal proteins SMI311 (B) or NeuN (C), demonstrating their neuronal identity. D panels show higher magnification images of two neurons showing immunopositivity for both GPR17 (red channel, D), and NeuN (green channel, D'); (D'') merge of the two fluorescence channels. In cortex, we found no co-localization of GPR17 with the astroglial markers GFAP (E) and S100beta (F, arrows indicate GPR17+ cells); several ramified GPR17-labeled cells instead co-stained for either NG2 (blue arrows in G) or Olig2 (H, H'), which are both pre-oligodendrocyte markers. However, in the case of NG2, only a partial co-localization was found, since some cells only stained for NG2 (arrowheads in G) and some others only stained for GPR17 (white arrows in G, H). Co-localization was much higher in the case of GPR17 and Olig2 (see text for quantification). In some cases, NG2+ or Olig2+ cells show immunoreactivity for GPR17 in discrete cell body compartments (inset in G and H'', respectively; for details, see text). I and J depict no co-localization of GPR17 with myelin-related proteins (CNPase in I and MAG in J). Some "resting" microglial cells were also found in cortex, as suggested by staining with the specific marker Iba1 (K): in the intact brain, none of these cells expressed GPR17. Scale bars: A: 25 microm; A', D, D', D'', H', H'': 10 microm; B, E, F, G: 50 microm; H, I, J, K: 20 microm.
###end p 19
###begin p 20
###xml 180 191 180 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2H&#8243;</xref>
###xml 205 214 204 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2G</xref>
###xml 380 381 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 805 814 804 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2I</xref>
###xml 853 862 852 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2J</xref>
###xml 1129 1138 1128 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2K</xref>
Interestingly, in some Olig2 or NG2-labeled cells, GPR17 immunoreactivity displayed an asymmetrical subcellular localization, suggesting GPR17 accumulation in the Golgi apparatus (Figure 2H'' and inset in Figure 2G). This specific staining pattern may represent a well defined GPR17 maturation stage prior to distribution of the receptor to the plasma-membrane. The branched GPR17+ cells did not incorporate BrdU in their nuclei, at least under the conditions of BrdU treatment utilized here (data not shown), suggesting that, in the intact brain, GPR17 decorates a subset of quiescent non-proliferating parenchymal oligodendrocyte precursors. Furthermore, no colocalization of GPR17 was found with more mature myelinating oligodendroglial markers, as shown by lack of double-staining with either CNPase (Figure 2I), myelin-associated glycoprotein MAG (Figure 2J) and myelin basic protein MBP or APC (data not shown), suggesting that GPR17 may be expressed at a specific stage of oligodendroglial differentiation. Finally, no GPR17 co-expression was found in resting microglia detected by anti-Iba1 staining in the intact brain (Figure 2K) (however, see: "Expression pattern of GPR17 during ischemia evolution").
###end p 20
###begin p 21
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 343 352 343 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003579.s002">Figure S2</xref>
###xml 204 215 <span type="species:ncbi:64105|species:ncbi:43770">c. striatum</span>
GPR17+ ramified cells were also found in corpus callosum: most of these cells co-stained for Olig2 but not with NG2 and did not seem to proliferate under resting conditions (not shown). Interestingly, in c. striatum, GPR17+ precursor cells were not positive for MBP, but were often found physically associated to or inside myelinating fibers (Figure S2).
###end p 21
###begin p 22
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adult</italic>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Maisel1">[12]</xref>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 465 469 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Spassky1">[18]</xref>
###xml 493 502 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g003">Figure 3A</xref>
###xml 584 593 581 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g003">Figure 3A</xref>
###xml 657 658 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 870 881 864 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g003">Figure 3B&#8211;D</xref>
###xml 972 981 966 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g003">Figure 3B</xref>
###xml 1037 1046 1031 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g003">Figure 3D</xref>
###xml 1095 1096 1089 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1129 1130 1123 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1151 1155 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Doetsch1">[19]</xref>
###xml 1157 1161 1151 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Seri1">[20]</xref>
###xml 1163 1167 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Garcia1">[21]</xref>
###xml 1190 1191 1184 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1259 1268 1253 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g003">Figure 3E</xref>
###xml 1383 1384 1377 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
Based on previous data demonstrating that GPR17 is one of the 3 key genes expressed in human adult NPCs [12], we also looked at the presence of GPR17+ cells in classical mouse brain neurogenic areas, i.e., the subventricular zone (SVZ) of lateral ventricles (LV) and the dentate gyrus (DG) of hippocampus. The first layer of brain ventricles wall consists of ependymal cells, i.e., radial glia-derived cells that intensively stain for the astrocyte marker S100beta [18] (green fluorescence in Figure 3A). Several of these cells were also immunoreactive for GPR17 (red fluorescence in Figure 3A; cells expressing both S100beta and GPR17 are in yellow). GPR17+ ramified cells with a morphology very similar to that of the parenchymal precursors described above were also detected immediately below the ependyma as well as in more profound layers of the subependymal zone (Figure 3B-D). These cells never co-stained with either the stem cell marker nestin (not shown), GFAP (Figure 3B) or the neuronal precursor marker double-cortin (DCX) (Figure 3D), suggesting that GPR17 is not expressed by GFAP+ multipotent stem cells or by DCX+ neuronal precursors [19], [20], [21]. Highly branched GPR17+ cells were also found in the subgranular layer of the hippocampus (Figure 3E); also here, no colocalization of GPR17 with the adult neural stem cell marker GFAP was found. None of these GPR17+ precursors proliferated under normal conditions.
###end p 22
###begin title 23
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
GPR17 expression in the mouse germinative zones.
###end title 23
###begin p 24
###xml 580 581 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 645 653 639 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2</xref>
###xml 679 680 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 923 924 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1090 1091 1084 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1278 1279 1272 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1172 1183 <span type="species:ncbi:64105|species:ncbi:43770">c. striatum</span>
Micrographs depicting GPR17 staining in coronal sections of the intact anterior forebrain. (A) In the walls of the lateral ventricles (LV), GPR17 (red fluorescence) is highly expressed in ependymal cells, which are in direct contact with ventricle cavities and also express the S100beta protein (green fluorescence). Cells co-expressing both GPR17 and S100beta in this cell layer are indicated in yellow. (B, C) Specific GPR17 staining (red fluorescence) is also found in the subependymal layer of LV. (B): several of these cells show a morphology that is reminiscent of the GPR17+ oligodendrocyte precursors found in brain parenchyma (see also Figure 2 and panel D). These GPR17+ cells do not co-stain for the astrocytic marker GFAP (green fluorescence in B), that is also specifically expressed by multipotent adult stem cells. (C) As expected, in the subependymal layer of lateral ventricles, several double-cortin (DCX)+ neuronal precursors are evident (red fluorescence); however, these cells do not co-express GPR17 (here shown in green fluorescence). (D) An additional image of GPR17+ ramified precursors (red fluorescence) in LV subependymal layer (arrows) and in c. striatum (CST) of brain parenchyma (Hoechst 33258 staining of cell nuclei is also shown in blue). GPR17+ cells in the subependymal layer were often found to protrude their processes in the ventricular cavity. (E) Double fluorescence image showing expression of GPR17 (red fluorescence) in ramified cells in the hippocampus (DG: dentate gyrus). Also in this brain area, GPR17 immunoreactivity does not co-localize with GFAP (green fluorescence). Scale bars: A-C 50 microm; D 10 microm; E 100 microm.
###end p 24
###begin p 25
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 444 445 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 460 461 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Globally, the data described above show that, in the intact mouse brain, GPR17 is expressed by neurons and by a subset of precursor cells in both parenchyma and neurogenic areas. In the parenchyma, GPR17 segregates to a subset of NG2+/Olig2+ precursor cells that never proliferated under control conditions, suggesting that there are quiescent pre-oligodendrocytes. In the neurogenic areas, GPR17 decorates a subset of non-proliferating, nestin-, GFAP- and DCX- cells of yet undefined nature.
###end p 25
###begin title 26
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Activation of GPR17 in vitro by the endogenous agonists UDP-glucose and LTD4 promotes pre-oligodendrocyte differentiation to mature myelinating cells
###end title 26
###begin p 27
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 203 214 203 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4A&#8211;H</xref>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 447 456 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4A</xref>
###xml 465 474 465 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4B</xref>
###xml 483 492 483 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4C</xref>
###xml 510 519 507 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4D</xref>
###xml 926 930 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-AlvarezBuylla1">[22]</xref>
###xml 932 936 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-deCastro1">[23]</xref>
###xml 943 944 940 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 998 1007 995 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4E</xref>
###xml 1043 1052 1040 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4F</xref>
###xml 1087 1096 1084 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4G</xref>
###xml 1238 1247 1235 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4H</xref>
###xml 1528 1537 1525 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4I</xref>
###xml 1655 1664 1652 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4I</xref>
###xml 1672 1675 <span type="species:ncbi:10116">rat</span>
To gain more information on the role of GPR17 in pre-oligodendrocyte precursors, we characterized the behaviour of these cells in mixed neuron/glia cortical cultures, where many GPR17+ cells were found (Figure 4A-H). These cells displayed a very typical highly ramified morphology resembling that of the precursor cells found in vivo. As also observed in the intact brain for the parenchymal precursors, these GPR17+ cells never expressed nestin (Figure 4A), GFAP (Figure 4B), MAP2 (Figure 4C) or beta-TubIII (Figure 4D), suggesting that they are not stem cells, nor astrocytes or neurons. To investigate in detail whether GPR17 is specifically expressed by pre-oligodendrocytes, we performed double staining experiments with a set of markers identifying different stages of differentiation, i.e., NG2 (oligodendrocyte precursor), O4 and CNPase (pre-oligodendrocytes, immature/mature cells), and MBP (mature oligodendrocytes) [22], [23]. GPR17+ cells were found to co-express either NG2 (arrows in Figure 4E), Olig2 (not shown), O4 (arrows in Figure 4F), or, to a lesser extent, CNPase (Figure 4G), confirming that they are indeed oligodendrocyte precursors. Conversely, very few cells co-expressed the mature oligodendrocyte marker MBP (Figure 4H; see also below). Expression of GPR17 in oligodendrocyte precursors was also confirmed by single-cell PCR. For this analysis, one cell or a small group of cells (up to 10) were picked up from living cultures using cell morphology as a guide at the light microscope (see arrows in Figure 4I). Receptor expression was detected in both the single-cell and the 10-cell samples, as indicated in the PCR panel of Figure 4I, where rat cortex was utilized as a positive control.
###end p 27
###begin title 28
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Presence and activation of GPR17 in oligodendrocyte precursor cells of primary cortical cultures maintained in vitro.
###end title 28
###begin p 29
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 671 672 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1657 1678 1654 1675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">MATERIALS AND METHODS</xref>
###xml 1969 1970 1962 1963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2038 2046 2031 2039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2093 2094 2086 2087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2186 2187 2179 2180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2561 2562 2550 2551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2606 2607 2595 2596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2781 2782 2770 2771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 2870 2871 2859 2860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2907 2908 2896 2897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1837 1840 <span type="species:ncbi:10116">Rat</span>
Several GPR17+ ramified cells (green fluorescence) reminiscent of the precursors found in vivo were consistently found in primary neuron/glia cortical cultures. Micrographs (A-H) show their phenotype characterization. These cells (green fluorescence) did not co-express the stem cell marker nestin (A), or the astrocytic marker GFAP (B), or the neuronal markers MAP2 (C) and beta-TubIII (D), but were instead positive for several pre-oligodendrocyte markers, such as NG2 (arrows in E) and O4 (arrows in F), which appear quite early during oligodendrocyte differentiation. Colocalization of GPR17 with these markers is shown in yellow-orange cells. A lower number of GPR17+ cells also expressed CNPase (arrow in G) and very few costained for MBP (arrow in H), which are markers of more mature oligodendroglia (for more details, see text). In blue, Hoechst 33258 stained nuclei. Single cell RT-PCR was used to confirm expression of GPR17 in oligodendroglial-like cells (I). For this analysis, cells were picked up from living cultures using cell morphology as a guide at the light microscope. Left micrograph: an example of a brightfield showing cells (arrows) with oligodendrocyte morphology. These cells can be distinguished from neurons based on their size (approximately 1/3 the size of neurons), phase-dark cell bodies and presence of fine ramifications. The oligodendrocyte nature of cells with this morphology was confirmed by co-immunostaining for O4 and GPR17 at a subsequent time after culture fixing (arrows in right micrograph). By following this method, one living cell or a small number of cells (up to 10) were sucked from living cultures (see MATERIALS AND METHODS) and processed for RT-PCR analysis. Significant GPR17 expression was detected in both the single-cell and the 10-cell samples, as indicated in the PCR panel. Rat cortex was utilized as a positive control (see last lane). Scale bars: 15 microm. In these primary cultures, the number of GPR17+ cells spontaneously increased as a function of time (J); DIV: days in vitro. (K) Quantification of the percentage of GPR17+ cells that also co-express the indicated oligodendrocyte markers. Total number (n) of GPR17+ cells counted from two different coverslips for each preparation: for NG2, n = 3502; for O4, n = 2685; for CNPase, n = 1738; for MBP, n = 3615. Data were obtained from five different primary culture preparations. (L) Exposure of cultures to maximal (100 microM) UDP-glucose (UDP-glc) concentrations for 72 h induced a highly significant increase in the number of mature MBP+ oligodendroglial cells. The number of GPR17+ cells was also increased. Both effects were partially counteracted in the presence of the P2Y receptor antagonist cangrelor. (M) Exposure of cultures to maximal (100 nM) LTD4 concentrations for 72 h also induced a significant increase in the number of mature MBP+ oligodendroglial cells and of GPR17+ cells. No synergistic nor additive effects were found when both agonists were combined together. There were no significant changes in the total number of cells in culture during the 72 h treatment, as shown by labeling of cells nuclei with Hoechst 33258. *p<0.05 compared to control; ** p<0.05 with respect to UDP-glc and not different from control; # p = 0.15 with respect to control and P = 0.245 with respect to UDP-glc, one-way analysis of variance (ANOVA).
###end p 29
###begin p 30
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 79 88 79 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4J</xref>
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 231 240 231 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4K</xref>
###xml 263 264 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The number of the GPR17+ precursors constantly increased with time in culture (Figure 4J). A quantification of the percentage of the GPR17+ cells at various oligodendrocyte differentiation stages in 10-day old cultures is shown in Figure 4K. A prevalence of GPR17+ cells expressing early oligodendroglial markers such as NG2 or O4, was constantly found. No significant relative changes of this distribution was observed with time in culture, at least up to day 20 (data not shown).
###end p 30
###begin p 31
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 714 722 708 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 888 889 880 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1057 1058 1049 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1083 1092 1075 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4L</xref>
###xml 1238 1239 1230 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1293 1294 1285 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1309 1310 1301 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1335 1344 1327 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4M</xref>
###xml 1434 1443 1426 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4M</xref>
###xml 1636 1652 1628 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4L and 4M</xref>
###xml 1778 1786 1770 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In order to verify whether GPR17 in cultured precursors is functional and whether its activation can promote cell progression along their differentiation pathway, cultures were treated with UDP-glucose, which selectively binds to this receptor and activates it [11]. Exposure of cultures to a maximal concentration (100 microM) of UDP-glucose for 72 h did not have any effect on cell viability, as demonstrated with propidium iodide (PI) that does not enter viable intact cells and can only label the nuclei of cells with damaged permeabilized membrane. In control cultures, PI labeled a small percentage of cells (16.3+/-3.5%, n = 4). This low percentage of cell death, which is reasonably expected for a primary in vitro culture, was not different in UDP-glucose treated cells (13.7+/-1.9%, n = 4). UDP-glucose treatment instead resulted in a significant increase of the number of GPR17+ precursor cells, suggesting that activation of the receptor may itself promote receptor expression, and, more important, it markedly increased the number of mature MBP+ oligodendroglial cells (Figure 4L). Both effects were partially counteracted by the P2Y receptor antagonist cangrelor (ibidem). Exposure to a maximal concentration (100 nM) of LTD4 also significantly increased both the number of GPR17+ and mature MBP+ oligodendroglial cells (Figure 4M). No synergistic effects were observed when cells were treated with a combined protocol (Figure 4M). The total number of cells in culture did not significantly increase during the 72 h treatment period with pharmacological agents, as suggested by labeling of cell nuclei with Hoechst 33258 (Figure 4L and 4M), to support the conclusion that, in these cultures, activation of GPR17 by its endogenous agonists is actually inducing the in vitro maturation of already existing oligodendrocyte precursors.
###end p 31
###begin p 32
Thus, GPR17 is already functional in pre-oligodendrocytes and its activation promotes the progression of these cells along their differentiation pathway.
###end p 32
###begin title 33
Expression pattern of GPR17 during ischemia evolution
###end title 33
###begin p 34
###xml 255 264 255 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5A</xref>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5C</xref>
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 451 460 451 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5B</xref>
###xml 756 765 756 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5D</xref>
###xml 897 906 897 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5D</xref>
###xml 1015 1024 1015 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5E</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Armstrong1">[24]</xref>
###xml 1402 1423 1402 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5, right panel</xref>
###xml 1958 1959 1958 1959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
###xml 161 165 <span type="species:ncbi:10090">MCAo</span>
###xml 249 253 <span type="species:ncbi:10090">MCAo</span>
###xml 554 558 <span type="species:ncbi:10090">MCAo</span>
###xml 1347 1351 <span type="species:ncbi:10090">MCAo</span>
###xml 1697 1701 <span type="species:ncbi:10090">MCAo</span>
To characterize the changes of GPR17 occurring during ischemic damage, mouse brains were processed for immunohistochemistry at 24, 48, 72 hours and 1 week after MCAo. Within the lesioned area, a strong up-regulation of GPR17 was observed 24 h after MCAo (Figure 5A) with respect to the corresponding unlesioned area of the contralateral cortex (Figure 5C). Inside the injured area, most of the GPR17+ cells co-localized with the neuronal marker NeuN (Figure 5B), suggesting that receptor up-regulation indeed occurred in neurons. Forty-eight hours after MCAo, a dramatic decrease of both the number of neuronal cells and of GPR17 immunoreactivity was found inside the lesion, suggesting that neurons over-expressing GPR17 at 24 h had undergone cell death (Figure 5D). Several shrunk cells overexpressing GPR17 and resembling damaged neurons were also found at the borders of the ischemic infarct (Figure 5D). Some of these cells also positively stained for NeuN (data not shown) and for the chaperon protein HSP70 (Figure 5E), which is known to be up-regulated in neurons upon damage [24]. Western blot analysis of GPR17 performed in membrane (M) and cytosolic (C) fractions confirmed increased expression of a membrane protein band of approximately 50 kDa (likely corresponding to a glycosylated form of the receptor) in the lesioned hemisphere (MCAo) compared to the intact contralateral (Con) side (Figure 5, right panel). As expected for a membrane receptor, no specific signal for the anti-GPR17 antibody was detected in cytosolic fractions (ibidem). To confirm that this band is indeed GPR17, immunolabeling was abolished in the presence of the neutralizing peptide. A quantification of the MCAo-induced up-regulation of GPR17 is shown in histograms. Globally, these findings suggest that, upon damage, GPR17 is up-regulated in injured neurons and that this up-regulation may be causally related to cell death. At this stage of damage development, GFAP+ activated astrocytes indicating astrogliosis were also visible at the borders of the injured area, but none of these cells expressed GPR17 (data not shown).
###end p 34
###begin title 35
###xml 38 42 <span type="species:ncbi:10090">MCAo</span>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Time course of GPR17 expression after MCAo in mice.
###end title 35
###begin p 36
###xml 679 680 679 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1834 1835 1834 1835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2085 2086 2085 2086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2090 2091 2090 2091 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">MCAo</span>
###xml 190 194 <span type="species:ncbi:10090">MCAo</span>
###xml 668 672 <span type="species:ncbi:10090">MCAo</span>
###xml 1156 1160 <span type="species:ncbi:10090">MCAo</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
###xml 1616 1620 <span type="species:ncbi:10090">MCAo</span>
###xml 1789 1793 <span type="species:ncbi:10090">MCAo</span>
###xml 2155 2159 <span type="species:ncbi:10090">MCAo</span>
Micrographs show coronal brain slices obtained from mice 24, 48, 72 hours after MCAo. Brain drawings in insets show the areas (squares) where micrographs were taken. (A) Twenty-four h after MCAo, immunohistochemistry with an anti-GPR17 antibody (red fluorescence) show a marked up-regulation of the receptor within the ischemic lesioned area (the region delimited by the dotted line). Basal expression of GPR17 in the corresponding contralateral area is shown in C for comparison. (B) Cells showing marked GPR17 expression inside the lesioned area also express the specific neuronal marker NeuN, confirming that these cells are indeed neurons. (D) Forty-eight h after MCAo, GPR17+ neurons inside the lesioned area are markedly reduced, suggesting induction of cell death. At this time point, a marked up-regulation of GPR17 appears in neurons at the border of the lesion. (E) These cells co-localize with the neuronal damage marker HSP70 (see text for more details). Up-regulation of GPR17 in the ischemic area is also confirmed by western blot analysis in membrane (M) and cytosolic (C) fractions from intact contralateral (Con) and ipsilateral ischemic (MCAo) cortex of mice (right panel). GPR17 is identified with an anti-GPR17 antibody as an immunoreactive protein band with an approximate 50 kDa molecular weight; as expected for a membrane receptor, this band is present in membranes but not in cytosolic fractions. To confirm blot specificity, the 50 kDa protein band is abolished in the presence of the neutralizing peptide (indicated as+pept). A marked increase of the intensity of this band is found after MCAo (the quantification of this increase is shown in histograms as % of control set to 100%; results from 5 experiments). Forty-eight h (not shown) and seventy-two h after MCAo (F), there is a marked increase of GPR17+ cells at the border of the lesioned area. (G) These cells are not neurons but they are microglia/macrophages infiltrating the ischemic area, since most of them also positively stain for IB4, a microglia/macrophage marker (see also text). These GPR17+/IB4+ cells are indeed found inside the lesioned area one week after MCAo (data not shown). Scale bars: 50 microm.
###end p 36
###begin p 37
###xml 143 152 143 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5F</xref>
###xml 276 285 276 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5G</xref>
###xml 540 541 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 58 62 <span type="species:ncbi:10090">MCAo</span>
###xml 437 441 <span type="species:ncbi:10090">MCAo</span>
Starting from 48 h and highly evident seventy-two h after MCAo, a marked expression of GPR17 was found at the boundaries of the lesioned area (Figure 5F), but this time immunoreactivity was associated to cells also expressing IB4, a marker of activated microglia/macrophages (Figure 5G). Under the staining conditions utilized here, no specific IB4 labeling was detected in the intact contralateral side (data not shown). One week after MCAo, GPR17 immunopositivity was again increased within the damaged area: also these cells were all IB4+, suggesting that they are indeed the macrophages/microglia found at the lesion borders at day 3, that were now infiltrating the lesioned area (data not shown). These data show that after up-regulation in neurons, there is a second wave of GPR17 induction in microglia/macrophages as soon as these cells are activated and recruited toward the lesioned area as a consequence of damage.
###end p 37
###begin p 38
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Maisel1">[12]</xref>
###xml 50 58 50 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g003">Figure 3</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Okano1">[25]</xref>
###xml 285 292 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 329 337 329 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g006">Figure 6</xref>
###xml 583 584 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 590 591 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 774 783 774 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g006">Figure 6A</xref>
###xml 817 826 817 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g006">Figure 6B</xref>
###xml 933 941 933 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5</xref>
###xml 1093 1101 1093 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2</xref>
###xml 1112 1121 1112 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g006">Figure 6C</xref>
###xml 1162 1171 1162 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5D</xref>
###xml 1184 1193 1184 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5E</xref>
###xml 1228 1229 1228 1229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1397 1398 1397 1398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1772 1788 1770 1786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g006">Figure 6F and 6G</xref>
###xml 1925 1926 1923 1924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1930 1931 1928 1929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1961 1970 1959 1968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g006">Figure 6H</xref>
###xml 2001 2002 1999 2000 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 267 271 <span type="species:ncbi:10090">MCAo</span>
###xml 350 354 <span type="species:ncbi:10090">MCAo</span>
###xml 1272 1283 <span type="species:ncbi:64105|species:ncbi:43770">c. striatum</span>
###xml 2090 2094 <span type="species:ncbi:10090">MCAo</span>
Based on the demonstration of GPR17 on NPCs [12] (Figure 3) and on the finding that ischemic damage induces proliferation of adult NPCs in brain's neurogenic areas and parenchyma [25], we investigated whether cells expressing GPR17 also underwent proliferation after MCAo, as assessed in vivo by BrdU administration. As shown in Figure 6, 72 h after MCAo, a marked increase in the number of proliferating cells was found in the lesioned ipsilateral hemisphere with respect to the corresponding unlesioned side (compare green dots in brain's schematic drawing). Two main types of BrdU+/GPR17+ cells were found in the ischemic side. The first cells were mainly found at the borders of the injured area (indicated as 1 in brain's drawing) and appeared as small globular cells (Figure 6A) which markedly stained for IB4 (Figure 6B). So, these cells are the microglia/macrophages about to infiltrate the lesioned tissue, already shown in Figure 5. The morphology of the second proliferating cell type very closely resembled the parenchymal highly branched pre-oligodendrocytes already described in Figure 2 (see also Figure 6C) and positively stained for both GPR17 (Figure 5D) and Olig2 (Figure 5E). These parenchymal branched GPR17+ precursors were consistently found in the c. striatum (indicated as 2 in brain drawing) as well as in regions closer to the lesion borders. Quantification of the GPR17+ precursor cells in 3 animals revealed a 24.07+/-5.23% increase in number with respect to the unlesioned contralateral side (total number of cells counted: 2542 and 2039 in the ischemic versus the contralateral side). At variance from the intact brain, in the injured brain, some of these precursor cells also positively stained for APC, a marker of mature oligodendroglia (Figure 6F and 6G). As expected, brain injury also induced the activation of precursor cells in the SVZ (indicated as 3 in brain drawing), where many BrdU+/DCX+ cells started proliferating (Figure 6H). However, no changes in GPR17+ cells were found in this neurogenic area (not shown) at least at this time frame after MCAo.
###end p 38
###begin title 39
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 80 84 <span type="species:ncbi:10090">MCAo</span>
Characterization of proliferating cells in adult mouse brain after induction of MCAo.
###end title 39
###begin p 40
###xml 307 328 307 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 563 564 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 595 596 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 876 884 876 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g005">Figure 5</xref>
###xml 915 916 915 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 922 923 922 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 974 975 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1058 1066 1058 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2</xref>
###xml 1632 1633 1632 1633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1637 1638 1637 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">MCAo</span>
###xml 351 355 <span type="species:ncbi:10090">MCAo</span>
###xml 1097 1108 <span type="species:ncbi:64105|species:ncbi:43770">c. striatum</span>
To evaluate injury-induced cell proliferation, BrdU (50 mg/Kg) was administered twice a day for 3 days to ischemic mice starting from the afternoon of MCAo. Animals were sacrified 4 h after the last BrdU injection and coronal brain slices prepared for immunohistochemical analysis (for further details, see Materials and Methods). Seventy-two h after MCAo, a marked increase of BrdU+ cells is found in the ipsilateral lesioned hemisphere with respect to the contralateral unlesioned side (compare green dots in brain's drawing). Many of these cells are also GPR17+. Two main types of BrdU+/GPR17+ cells are found. (A, B) A first, small globular cell type is mainly found in the peri-lesioned area (indicated as 1 in brain's drawing); these cells also markedly stain for IB4 and are indeed the microglia/macrophages about to infiltrate the ischemic lesion already described in Figure 5. (C-E) A second, ramified BrdU+/GPR17+ cell type (D) reminiscent of the parenchymal Olig2+ pre-oligodendrocytes (C, E; see also text) already described in the intact brain (Figure 2) is consistently found in the c. striatum (indicated as 2 in brain drawing) as well as in regions closer to the lesioned area (not shown). The number of these cells was significantly higher in the ipsilateral with respect to the unlesioned contralateral side (see text for more details). (F, G) Some of these proliferating precursor cells also positively stained for APC, a marker of mature oligodendroglia, suggesting initiation of re-myelination. (H) As expected, in the ispilateral SVZ (indicated as 3 in brain drawing), a marked increase of double-positive BrdU+/DCX+ cells is found with respect to the unlesioned hemisphere. However, none of these cells expressed GPR17 (not shown). Scale bars: 50 microm.
###end p 40
###begin p 41
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Globally, these data show that induction of brain damage is associated to activation of GPR17. Very early (24 h) after the insult, GPR17 is transiently upregulated in neurons (which already express this receptor under physiological conditions) in parallel with the appearance of the cellular stress marker HSP70. GPR17 labeling in the lesioned area decreases as cell death progresses. Starting from 48-72 h after ischemia, GPR17 immuno-labeling appears on microglia/macrophages infiltrating the injured area. At this stage, a subset of GPR17+ oligodendrocyte progenitors in the peri-lesion area start to proliferate and to express mature oligodendroglia markers, suggesting differentiation to mature cells.
###end p 41
###begin title 42
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
The in vivo knock down of GPR17 markedly attenuates brain ischemic damage in mice
###end title 42
###begin p 43
###xml 425 432 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 541 545 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Stein1">[26]</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Tepper1">[27]</xref>
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-VanOekelen1">[28]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 1141 1145 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 1423 1438 1423 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g007">Figure 7 legend</xref>
###xml 1761 1770 1761 1770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g007">Figure 7A</xref>
###xml 1801 1810 1801 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g007">Figure 7B</xref>
###xml 195 199 <span type="species:ncbi:10090">MCAo</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">MCAo</span>
###xml 692 696 <span type="species:ncbi:10116">rats</span>
###xml 1063 1068 <span type="species:ncbi:10090">mouse</span>
###xml 1137 1140 <span type="species:ncbi:10116">rat</span>
###xml 1157 1162 <span type="species:ncbi:10090">mouse</span>
###xml 1323 1327 <span type="species:ncbi:10090">MCAo</span>
###xml 1413 1417 <span type="species:ncbi:10090">MCAo</span>
The data shown above suggest that GPR17 may represent a "sensor" of damage activated very early during ischemia induction and contributing to cell death. If this were true, its inhibition during MCAo should contrast cell death inside the ischemic core and attenuate the evolution of ischemic damage. To address this issue, 6 mice received an anti-sense oligonucleotide (616) specifically designed to knock down this receptor in vivo. Animals were injected intracerebroventricularly 20 min and 24 h after MCAo. This biotechnological strategy [26] has been proven to very efficiently downregulate other GPCRs in the brain [27], [28] and has been already successfully utilized by us in ischemic rats [11]. Another group of 6 animals received in parallel a "scrambled" oligonucleotide randomly generated on the basis of the nucleotide sequence of 616. This group of animals was utilized as a control group in this set of experiments. Finally, another group of 6 animals received Cangrelor, that, although not selective for GPR17 (see "Cloning and characterization of mouse GPR17"), has been shown by us to potently inhibit GPR17 in both the rat [11] and in the mouse (the present study). The evolution of ischemic damage was followed longitudinally in living animals by Magnetic Resonance Imaging (MRI) at 2, 24 and 48 h after MCAo. There were no changes between groups in the mean brain ischemic volume at 2 h after MCAo (see Figure 7 legend). In the lesioned hemispheres of animals receiving the scrambled oligonucleotide, as expected, brain infarct volume increased dramatically between 2 and 48 h. Conversely, in animals treated with 616, progression of ischemic damage at 24 and 48 h was markedly reduced, and, in the case of Cangrelor, totally abolished (see Figure 7A for representative images and Figure 7B for quantification and statistical analysis).
###end p 43
###begin title 44
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Effect of the in vivo knock down of GPR17, by either a biotechnological or a pharmacological strategy, on brain infarct size evolution, as determined by MRI.
###end title 44
###begin p 45
###xml 693 714 693 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">MATERIALS AND METHODS</xref>
###xml 881 882 875 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">MCAo</span>
###xml 495 499 <span type="species:ncbi:10090">MCAo</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">MCAo</span>
(A) Representative Tr(D) images of coronal brain sections from ischemic mice treated with either an anti-sense oligonucleotide specifically designed to knock down GPR17 (616) or Cangrelor (Can), in comparison with animals treated with a "scrambled" randomly designed oligonucleotide (Scr). Images were taken from the same animals at 2, 24 and 48 h after MCAo. Dotted lines indicate the extension of the ischemic infarct. (B) Quantitative analysis of infarct size volume at 24 and 48 hours after MCAo in mice receiving Scr, 616 or Can (mean of 6 animals/group). Data are expressed as percentage variation of infarct volume at 24 and 48 h after MCAo compared to 2 h considered as 100% (see also MATERIALS AND METHODS). There were no statistically significant differences between groups in the ischemic infarct volumes at 2 h (Src = 23.4+/-7.47; 616 = 23.9+/-7.2; Can = 16.4+/-4.23 mm3). **P<0.001 versus 2 h; # P<0.05 versus corresponding Scr animals.
###end p 45
###begin p 46
###xml 132 153 132 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">MATERIALS AND METHODS</xref>
Bioinformatic analysis showed that 616, that effectively reduced brain infarct evolution, was not homologous to any other GPCR (see MATERIALS AND METHODS). This strongly indicates that GPR17 is indeed the specific target of 616, thus confirming a specific role for this receptor in the changes associated to ischemic damage development.
###end p 46
###begin title 47
Discussion
###end title 47
###begin title 48
GPR17: a receptor with a dual role in both neuronal death and in brain repair?
###end title 48
###begin p 49
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Maisel1">[12]</xref>
###xml 508 513 <span type="species:ncbi:9606">human</span>
We have previously suggested that an up-regulation of the hybrid nucleotide/cysteinyl-leukotriene receptor GPR17 in the ischemic brain may contribute to the evolution of damage [11]. A causal link between up-regulation of GPR17 and extent of brain damage was suggested by data showing that inhibition of GPR17 by either pharmacological agents or by an antisense-oligonucleotide strategy markedly attenuated cell death (ibidem). However, GPR17 has also been reported to be one of the 3 key genes expressed in human adult neuroprogenitor cells [12], which would instead suggest a potential role in brain repair. These apparently conflicting results suggest that GPR17 might play differential roles in different cell types and/or under specific pathophysiological conditions; for example, it may well be that, upon injury, GPR17 is induced in distinct cell types depending upon specific phases of damage development, remodeling and repair.
###end p 49
###begin p 50
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 374 378 <span type="species:ncbi:10090">MCAo</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
On this basis, the present study was purposely undertaken to (i) define the cellular localization of GPR17 in the intact mouse brain and shed light on its potential roles under physiological conditions; and (ii), to define possible changes of this receptor in the cell types that participate to brain damage and repair in a well-established focal ischemia model such as the MCAo model in the mouse.
###end p 50
###begin title 51
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
Mouse GPR17 closely reproduces the functional features of human GPR17
###end title 51
###begin p 52
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 955 959 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 961 969 961 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g001">Figure 1</xref>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 188 193 <span type="species:ncbi:10090">Mouse</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
###xml 349 352 <span type="species:ncbi:10116">rat</span>
###xml 460 465 <span type="species:ncbi:10090">mouse</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
###xml 620 623 <span type="species:ncbi:10116">rat</span>
###xml 680 685 <span type="species:ncbi:9606">human</span>
###xml 699 704 <span type="species:ncbi:10090">mouse</span>
###xml 809 812 <span type="species:ncbi:9606">man</span>
###xml 817 820 <span type="species:ncbi:10116">rat</span>
###xml 932 937 <span type="species:ncbi:9606">human</span>
###xml 942 947 <span type="species:ncbi:10090">mouse</span>
###xml 997 1002 <span type="species:ncbi:10090">mouse</span>
###xml 1056 1061 <span type="species:ncbi:9606">human</span>
###xml 1092 1097 <span type="species:ncbi:10090">mouse</span>
###xml 1098 1102 <span type="species:ncbi:10090">MCAo</span>
As a first step to these aims, we cloned and characterized the previously unknown mouse ortholog of GPR17 and compared its pharmacology with that of the already known human receptor [11]. Mouse GPR17 is 90% identical to the human receptor and, importantly, its response profile to ligands is closer to that of the human receptor with respect to the rat receptor. Despite some differences in the affinities of UDP and UDP-glucose, which were more potent at the mouse compared to the human receptor, potencies of cysLTs were in the same range. Moreover, while the endogenous ligand UDP-galactose is totally ineffective at rat GPR17, this nucleotide significantly activates both the human [11] and the mouse receptor (the present study). Finally, for antagonists, while there are significant differences between man and rat, the P2Y and CysLT blockers cangrelor and montelukast display almost identical antagonistic activities at both human and mouse GPR17 ([11]; Figure 1). Therefore, globally, the mouse receptor more closely reproduces the features of the human receptor, thus validating the mouse MCAo model utilized here as the most appropriate experimental model to assess the role of GPR17 in brain injury.
###end p 52
###begin title 53
GPR17 as a new player in oligodendrocyte differentiation
###end title 53
###begin p 54
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 826 835 826 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003579.s003">Figure S3</xref>
###xml 993 1002 993 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003579.s003">Figure S3</xref>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 850 855 <span type="species:ncbi:9606">human</span>
###xml 857 860 <span type="species:ncbi:10116">rat</span>
###xml 865 870 <span type="species:ncbi:10090">mouse</span>
Immunohistochemical studies with a specific, in-house made anti-GPR17 antibody showed that, in the intact mouse telencephalon, GPR17 is present on both neurons and in a subpopulation of ramified non proliferating Olig2+ or NG2+ precursor cells dispersed in both gray and white matter. In particular, the number of ramified precursors expressing both Olig2 and GPR17 is very high, to suggest that Olig2, which is a transcriptional factor, may drive the expression of GPR17 in these cells. By bioinformatic analysis, we indeed found 14 potential Olig2-responsive elements in the upstream region of the GPR17 gene. These responsive elements can bind to either Olig2 itself or to other members of the Olig2 transcription factor family, such as Atoh1, Neurod1, Neurod2, Neurod4, Neurod6, Neurog1, Neurog2, Neurog3, TGF12 and TGF3 (Figure S3). In both the human, rat and mouse GPR17 upstream regions, 6 phylogenetically conserved domains were found: two of them (indicated as E-Box 1 and E-Box 2 in Figure S3) are particularly interesting, since they are identical in the 3 species and contain 2 responsive elements for members of the Olig2 transcription factor family.
###end p 54
###begin p 55
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Arnett1">[29]</xref>
###xml 471 472 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 757 758 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 972 979 972 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 258 269 <span type="species:ncbi:64105|species:ncbi:43770">c. striatum</span>
In the intact brain parenchyma, none of the GPR17+ precursor cells expressed either GFAP, or DCX or mature oligodendrocyte/myelination markers, suggesting that GPR17 specifically decorates mature neurons and quiescent pre-oligodendrocytes. Interestingly, in c. striatum, immature GPR17+/MBP-negative precursor cells were often found physically associated to or inside myelin tracts, which have been previously shown to also contain immature Olig2+ cells [29]. These GPR17+ cells may represent a source of pre-oligodendrocytes able to turn into myelinating cells when necessary; alternatively, these cells could play a role in the local trophic control of myelination. To confirm the link between GPR17 and the oligodendroglial lineage, highly ramified GPR17+ precursors specifically expressing markers identifying different stages of oligodendrocyte differentiation are also present in primary cultures obtained from cortical parenchyma. In a similar way to what observed in vivo, under control conditions, these cells are not positive for either stem cell, neuronal or glial markers, and very few of them express MBP, a marker of mature oligodendroglia. This suggests that GPR17 expression is specifically segregated to the early stages of the oligodendrocyte differentiating pathway, and that the receptor is turned down when these cells reach functional maturation (in this respect, see also below).
###end p 55
###begin p 56
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 431 432 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 820 821 820 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In vivo, GPR17 is also present in both cells of the ependymal layer and in a subset of subependymal precursor cells of the lateral ventricles, one of the classical neurogenic areas that are still active in the adult brain. Again, none of these cells express either GFAP, nestin or DCX, suggesting that they are not "classical" multipotent neurogenic cells or neuronal precursors; moreover, in a similar way to the parenchymal GPR17+ precursor cells, they did not incorporate BrdU (at least under the experimental conditions utilized here). These cells may thus represent an additional yet-uncharacterized population of quiescent (or very slowly proliferating) precursors, or may be postmitotic SVZ-derived progenitors progressing along the oligodendroglial differentiation pathway. A similar population of ramified GPR17+ cells was also found in the hippocampus, another neurogenic area present in the adult brain.
###end p 56
###begin p 57
###xml 188 196 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 548 556 548 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 561 568 561 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 649 650 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 1221 1222 1221 1222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1434 1438 1434 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Gainetdinov1">[30]</xref>
To verify if GPR17 in oligodendrocytes precursors is indeed functional and could play a role in driving differentiation to mature myelinating cells, primary cortical cultures were treated in vitro with UDP-glucose, one of the endogenous agonists of GPR17 [11]. Exposure to this agonist for 72 h resulted in an approximately 3-fold increase of the number of mature MBP+ cells. To confirm the specificity of these effects, we demonstrated that the P2Y receptor antagonist cangrelor (that was previously demonstrated to contrast GPR17 activation both in vitro and in vivo[11], the present study), partially counteracted UDP-glucose induced changes. LTD4, which also acts as an agonist at GPR17 ([11]; the present study), induced similar effects, suggesting that activation of GPR17 on oligodendrocyte precursors by its endogenous agonists promotes progression along their differentiation pathway. In treated cultures, the total number of cells was not increased, to suggest that activation of GPR17 is actually inducing the maturation of already existing precursors. No synergistic nor additive effects were noticed when both agonists were combined together. However, since maximal concentrations of both UDP-glucose and LTD4 were used in this study, the plateau response may have been already achieved with the single agonist concentration, or the receptor may have undergone agonist-induced desensitization, a typical feature of GPCRs [30]. Future studies employing combinations of different agonist concentrations will clarify this aspect.
###end p 57
###begin p 58
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In line with these in vitro findings, application of a brain injury in vivo, such as induction of focal cerebral ischemia, promotes the activation of quiescent GPR17+ oligodendrocyte precursors that start proliferating in the parenchyma around the injured area. In the lesioned brain, some of these cells also start expressing more mature myelination markers such as APC, that are never expressed by quiescent GPR17+ precursors in the intact telencephalon (see also below).
###end p 58
###begin title 59
Upon brain ischemia, GPR17 is induced in several embryonically different cells that participate to damage evolution and repair
###end title 59
###begin p 60
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">MCAo</span>
We finally looked at the expression pattern of GPR17 in mice after induction of MCAo. We provide evidence that:
###end p 60
###begin p 61
###xml 486 487 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 695 702 695 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 828 836 828 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g007">Figure 7</xref>
###xml 251 255 <span type="species:ncbi:10090">MCAo</span>
Upon ischemia induction, there is an early, time-dependent up-regulation of GPR17 in neuronal cells both within and at the borders of the injured area. Numerous neurons over-expressing GPR17 are already evident inside the lesioned area 24 hours after MCAo. Several of these neurons co-localize with inducible HSP70, a marker of cellular stress, injury and death, suggesting a causal link between GPR17 up-regulation and neuronal death. To confirm this potential link, at 48 hours, GPR17+ neurons are no longer present inside the lesion suggesting that they have indeed undergone death. To further confirm a causative role of the receptor in induction of cell death inside the ischemic core, the in vivo knock down of GPR17 by either a pharmacological or a biotechnological approach markedly reduced the ischemic infarct volume (Figure 7).
###end p 61
###begin p 62
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 297 306 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g002">Figure 2K</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Stoll1">[31]</xref>
###xml 989 993 989 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Risinger1">[32]</xref>
###xml 32 36 <span type="species:ncbi:10090">MCAo</span>
###xml 324 328 <span type="species:ncbi:10090">MCAo</span>
Starting from 48-72 hours after MCAo, at the borders of the lesioned area, we found many GPR17+ cells that also strongly stained for IB4, a marker of activated microglia/macrophages. As expected, no IB4+ cells are found in the intact cortex, where all microglia was present in its "resting" form (Figure 2K). One week after MCAo, these cells are detected in high amount inside the ischemic lesion (data not shown). This pattern of IB4 positivity indeed reproduces the typical distribution of infiltrating cells in the ischemic brain [31]. It is not possible to establish whether these infiltrating cells are microglia or blood-borne macrophages or both, since under these experimental conditions both types of cells are positive to the same surface and endocellular markers (such as IB4). GPR17 immunoreactivity in these cells is not due to phagocytosis of GPR17 over-expressing neurons by microglia/macrophages, since none of these cells expresses typical neuronal markers such as SNAP25 [32].
###end p 62
###begin p 63
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Gregersen1">[33]</xref>
###xml 766 767 766 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 29 33 <span type="species:ncbi:10090">MCAo</span>
Starting from 72 hours after MCAo, the number of ramified GPR17+ oligodendrocyte precursor cells is also significantly increased both around the injured area and in the corpus striatum. These data are in line with previous literature data demonstrating that, in a similar way to neurons, oligodendrocytes are very vulnerable to brain damage in vivo and proliferation of oligodendrocyte precursor cells is detected after ischemia around the lesioned area [33], likely as a response to demyelination. Activation of oligodendrocyte precursor cells may contribute to the replenishment of oligodendrocytes and subsequent remyelination in the peri-injury area. In line with this hypothesis, at variance from the intact telencephalon, in ischemic animals, some of the GPR17+ parenchymal precursors also expressed typical mature oligodendroglia markers such as MBP (data not shown) and APC, to suggest that, upon damage, quiescent precursors are activated and start progressing along their differentiation pathway. Of course, in future experiments, it will be interesting to verify if, at later times after ischemia, these activated pre-oligodendrocytes start myelinating, thus actually supporting repair of demyelinated lesions.
###end p 63
###begin p 64
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Okano1">[25]</xref>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 486 487 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 633 636 633 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Melani1">[9]</xref>
###xml 710 711 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
In line with previous data demonstrating that ischemic insults activate precursor cells in classic neurogenic areas [25], many BrdU+/DCX+ cells were found in the SVZ of lesioned mice. However, none of these proliferating cells expresses GPR17, indicating a differential behaviour/regulation of GPR17+ precursors in brain parenchyma and in adult neurogenic areas. Based on the demonstration that GPR17 is specifically activated by uracil nucleotides and cysLTs (e.g., UDP-glucose and LTD4[11] and the present paper), and that, as a result of cell damage and death, massive release of nucleotides and cysLTs occurs in the injured area [9] we propose this differential behaviour be due to the fact that only GPR17+ precursor cells in the parenchyma have access to and can be activated by their endogenous ligand under these conditions.
###end p 64
###begin title 65
Conclusion
###end title 65
###begin p 66
In summary, our study reveals the new cysLT/uracil nucleotide receptor GPR17 as a "sensor" that is activated upon brain injury in several embryonically distinct cell types (neurons, microglia and adult neural precursor cells) that contribute to damage evolution and to the subsequent remodeling and repair. These findings are consistent with the emerging role played by endogenous cysLTs and nucleotides in the injured brain, when these molecules are released from damaged cells, rapidly diffuse in the extracellular environment and act as "danger signals" to alert responses to damage and start repair by ligating specific plasma membrane receptors on target cells. Our unpublished data demonstrate that GPR17 plays a similar role in other models of central nervous system neurodegenerative disease such as spinal cord injury, Alzheimer's disease and multiple sclerosis (manuscripts in preparation); thus, GPR17 may represents a sensor of local injury that is activated upon different kinds of lesions independently of the cause at the basis of damage. Initial up-regulation of GPR17 in neurons is followed by a second wave of receptor induction in microglial/macrophages recruited from distal parenchymal areas and moving towards the lesioned zone.
###end p 66
###begin p 67
Our study also reveals GPR17 as an important player in oligodendrocyte differentiation. At variance from other oligodendrogenic determinants, GPR17 is a membrane receptor that can be easily and immediately activated at the site of injury by its endogenous ligands to start remyelination. In addition, pharmacological strategies aiming to activate this receptor on pre-oligodendrocytes via small brain-permeable molecules may also directly contribute to implement intrinsic repair in post-ischemic regeneration as well as in demyelinating neurodegenerative conditions such as multiple sclerosis.
###end p 67
###begin title 68
Materials and Methods
###end title 68
###begin title 69
Cell culture and transfection
###end title 69
###begin p 70
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Fumagalli1">[15]</xref>
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 92 93 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 127 128 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 198 202 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Fumagalli1">[15]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human astrocytoma cells 1321N1 cells were cultured as described [15]. For [35S]GTPgammaS, 106 1321N1 cells were seeded on 75 cm2 flasks and transfected by the calcium phosphate precipitation method [15].
###end p 70
###begin p 71
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Bruzzone1">[34]</xref>
###xml 206 207 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 429 430 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 599 607 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1043 1044 1031 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1115 1116 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 82 101 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Primary mixed neuronal/glial cultures from cerebral cortex were obtained from E18 Sprague-Dawley rats according to standard procedures [34]. Pregnant animals were euthanized by cervical dislocation under CO2 anesthesia, and the fetuses removed and put into ice-cold Hanks balanced salt solution. After dissection of the cortices, cells were dissociated and plated on poly-L-lysine-treated 2.4 cm diameter glass coverslips (3.5x105 cells/coverslip) in Neurobasal (Invitrogen, Gibco) with 2% B27 containing 100 U/ml penicillin, 100 microg/ml streptomycin, 200 mM glutamine, 10 nM glutamate. At 3 days in vitro (DIV), half of the culture medium was replaced with fresh medium without glutamate. Double immunofluorescence experiments were performed between 3 to 10 DIV. At 10 DIV, some cultures were treated for 72 h with the following pharmacological agents: 100 microM UDP-glucose (Sigma-Aldrich), in the absence or presence of the P2Y receptor antagonist Cangrelor (10 microM, a gift of the Medicines Company, Parsippany, NJ, USA) or 100 nM LTD4 (Cayman Europe, Tallinn, Estonia) or the combined treatment 100 nM LTD4+100 microM UDP-glucose, and then fixed for immunostaining.
###end p 71
###begin title 72
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
RNA isolation, RT-PCR and cloning of mouse GPR17
###end title 72
###begin p 73
###xml 243 247 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Fumagalli1">[15]</xref>
###xml 325 353 323 351 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATGAACGGTCTGGAGGCAGCC-3&#8242;</named-content>
###xml 358 385 356 383 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCACAGCTCGGATCGGGCAC-3&#8242;</named-content>
###xml 410 411 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 590 593 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#169;</sup>
###xml 929 933 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Fumagalli1">[15]</xref>
###xml 1039 1054 1027 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003579-g004">Figure 4 legend</xref>
###xml 1131 1157 1119 1145 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTCTTCGCCTGCTTCTACC-3&#8242;</named-content>
###xml 1162 1188 1150 1176 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGGACGGCTTTATTCTTGA-3&#8242;</named-content>
###xml 1212 1213 1200 1201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 309 314 <span type="species:ncbi:10090">mouse</span>
###xml 504 509 <span type="species:ncbi:10090">mouse</span>
###xml 1117 1120 <span type="species:ncbi:10116">rat</span>
In the case of mouse tissue and 1321N1 cells, total RNA was extracted using the TRIZOL(R) Reagent (Invitrogen) according to the manufacturer's instructions. Retrotranscription to cDNA and PCR reactions were carried out as described previously [15]. The following primers were used to detect the expression of mouse GPR17: Fw 5'-GATGAACGGTCTGGAGGCAGCC-3'; Rv 5'-CTCACAGCTCGGATCGGGCAC-3' (PCR product: 1022 bp, TA: 61.4degreesC). The same primer pair, external to the open reading frame, was used to clone mouse GPR17 (NM_001025381) into a pcDNA3.1 expression vector using the pcDNA3.1/V5-His(c)TOPO(R) TA Expression Kit (Invitrogen, Milan, Italy). In the case of primary mixed neuronal/glial cultures, one living cell, (or a small group of cells, up to 10), was sucked into a patch pipette by applying a negative pressure, and then processed for RT-PCR, using oligo(dT) for retrotrascription (Invitrogen), as previously described [15]. Choice of oligodendrocyte cells was done at the light microscope, using cell morphology as a guide (see Figure 4 legend). The following primers were used to detect the expression of rat GPR17: Fw 5'-GCTCTTCGCCTGCTTCTACC-3'; Rv 5'-GCGGACGGCTTTATTCTTGA-3' (PCR product: 610 bp, TA: 58.6degreesC). Twenty microl aliquots of the PCR products were size separated by electrophoresis on a 1,5% agarose gel.
###end p 73
###begin title 74
###xml 1 3 1 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
[35S]GTPgammaS binding assay
###end title 74
###begin p 75
###xml 219 221 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 271 275 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
Control and transfected 1321N1 cells were homogenized in 5 mM TRIS-HCl, 2 mM EDTA, pH 7.4 and centrifuged at 48000 g for 15 min at 4degreesC. The resulting plasma membranes were suspended in binding buffer and used in [35S]GTPgammaS binding assay as previously described [11].
###end p 75
###begin title 76
Animals and treatments
###end title 76
###begin p 77
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Sironi1">[35]</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">MCAo</span>
###xml 471 475 <span type="species:ncbi:10090">MCAo</span>
###xml 681 685 <span type="species:ncbi:10090">MCAo</span>
Male CD1 mice (Charles River, Calco, Italy) weighing 20-25 g, after intraperitoneally anesthetized with ketamine (0.1 mg/kg) and xylazine (0.02 mg/kg), underwent permanent MCAo, as previously described [35]. Drug treatments were as follows: cangrelor (a single dose of 1.125 microg/animal in 4 microl of saline, a kind gift from The Medicines Company, Parsippany, NJ, USA) was administered intracerebroventricularly (i.c.v.) in the contralateral hemisphere, 20 min after MCAo; anti-sense oligonucleotide 616 and corresponding scrambled oligonucleotide (10 microg/animal, i.c.v., in 4 microl of saline) were administered twice in the contralateral hemisphere, 20 min and 24 h after MCAo. All i.c.v. administrations were performed 1 mm lateral to the middle line, 0.45 mm caudal to bregma, and 2.25 mm depth.
###end p 77
###begin p 78
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">MCAo</span>
Bromodeoxyuridine (BrdU; 50 mg/kg i.p., Sigma-Aldrich) was given by a single injection in intact mice to evaluate the proliferative activity of GPR17+ cells or twice daily for 3 days from 3 hours after MCAo. The animals were then euthanized 1 day, 2, or 3 days after the last injection. This study on animals has been approved by the Council of the Department of Pharmacological Sciences of the University of Milan, Italy, which is legally entitled for the use of animals for scientific proposes (D.M. of Italian Ministry of Health, Authorization # 124/2003 of 13/10/2003 and #143/2004 of 13/12/2004), which is, in turn, based on the D.L. of 27 January 1992 nr. 116. Implementation of European Union Directive nr. 86/609/CEE regarding the Protection of animals used for experimental and other scientific purposes.
###end p 78
###begin title 79
MRI analysis of ischemic damage development
###end title 79
###begin p 80
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 261 262 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 537 538 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 582 583 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 842 843 834 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 985 989 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Guerrini1">[36]</xref>
###xml 81 85 <span type="species:ncbi:10090">MCAo</span>
Brain infarct size was visualized by MRI measurements taken 2, 24 and 48 h after MCAo using a 4.7 T, vertical super wide bore magnet of a Burker Avance II spectrometer with micro imaging accessory. Animals were anesthetized with 1.5% isofluorane in 70% N2 30% O2, fixed on the holder and placed into the 3.8 cm diameter birdcage coil. A 3-orthogonal-plane, gradient echo scout acted as a geometric reference for locating the olfactory bulb; then, caudally, 12 contiguous coronal DW slices were acquired. The field of view was 2.56x1.6 cm2, the in plane resolution was 200x200 microm2 and the slice thickness was 800 microm in all the images. Spin echo DW images were acquired with 40 ms echo time and 1.5 s repetition time. Diffusion weighting was obtained by two 10 ms long and 25 ms spaced gradients resulting in a b value of about 900 s/mm2. Trace of diffusion tensor map computation, ischemic volume determination and progression of the ischemic damage over time were as described [36].
###end p 80
###begin title 81
Western Blot analysis
###end title 81
###begin p 82
###xml 629 635 <span type="species:ncbi:9986">rabbit</span>
Total protein extracts were obtained by tissue homogenization in 4 mM HEPES buffer, pH 7.3, containing 250 mM sucrose and protease inhibitors. The homogenate was centrifuged at 800 g for 10 min at 4degreesC, and then the supernatant was centrifuged at 200000 g for 1 h at 4degreesC to generate membrane and cytosolic fractions. The protein concentration was estimated by the Bradford procedure (Bio-Rad Laboratories). Equal amounts of protein from plasma-membranes and cytosolic fractions (30 microg) were loaded on 10% SDS-PAGE and blotted on nitrocellulose paper (Invitrogen). Nitrocellulose membranes were then incubated with rabbit anti-GPR17 polyclonal antibody (1:1000) for 2 h at RT. Specific signals were detected using the ECL immunoblotting detection system (Amersham Life Science).
###end p 82
###begin title 83
Immunohistochemistry, confocal and fluorescence microscopy
###end title 83
###begin p 84
###xml 317 321 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 727 731 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Buffo1">[16]</xref>
###xml 871 875 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 791 797 <span type="species:ncbi:9986">rabbit</span>
###xml 1004 1009 <span type="species:ncbi:10090">mouse</span>
###xml 1380 1383 <span type="species:ncbi:10116">rat</span>
###xml 1523 1529 <span type="species:ncbi:9986">rabbit</span>
GPR17 expression pattern was evaluated and confirmed on paraffin-embedded, frozen and floating brain sections. For paraffin embedding, the removed brains were fixed in Carnoy reagent, embedded in Paraplast (Sigma-Aldrich), and 8 microm coronal sections were processed for immunohistochemistry as previously described [11]. For frozen and floating sections, the animals have been perfused with with 4% paraformaldehyde in 0.01 M PBS and then incubated for 24 hours in a solution of 30% sucrose, embedded in OCT (Cell Path) and then frozen at -80degreesC. After perfusion and brain cryoprotection, 14 microm frozen sections or 30 microm floating sections were cut with a microtome or a vibratome, respectively, and treated as in [16]. Double labeling of brain sections was performed using the rabbit anti-GPR17 polyclonal antibody (1:100) generated as previously described [11] in combination with the selected primary antibody, in PBS 0.01 M, 0.1% Triton X-100. For co-localization studies, the following mouse monoclonal antibodies were used: anti-SMI311 (1:300, Sternberger Monoclonal Inc.), anti-NeuN (1:300, Chemicon), anti-GFAP (1:600, Cell Signalling), anti-S100beta (1:1000, Sigma-Aldrich), anti-CNPase (1:100, Chemicon), anti-MAG (1:500, Chemicon), anti-nestin (1:200, Chemicon), anti-HSP70 (1:3000, Sigma-Aldrich), anti-APC CC-1 clone (1:50, Calbiochem). In addition, the rat monoclonal anti-myelin basic protein (MBP; 1:200, Chemicon) and anti bromodeoxyuridine (1:150, Abcam) were used. Double labelings with the rabbit anti-Olig2 (1:800, Chemicon), anti-NG2 (1:200, Chemicon), doublecortin (DCX; 1:100, Cell Signalling), anti-Iba1 (1:1000, Wako Chemicals, Neuss, Germany), and with isolectin B4 (IB4) HRP-conjugated (1:100, Sigma-Aldrich) were also performed. When co-staining with primary antibodies developed in the same species, GPR17 was detected with the high sensitivity tyramide signal amplification kit (Perkin Elmer). Double labeling with anti-NG2 was performed using detergent free buffers.
###end p 84
###begin p 85
###xml 15 19 <span type="species:ncbi:9925">goat</span>
###xml 25 31 <span type="species:ncbi:9986">rabbit</span>
###xml 56 60 <span type="species:ncbi:9925">goat</span>
###xml 66 69 <span type="species:ncbi:10116">rat</span>
###xml 94 98 <span type="species:ncbi:9925">goat</span>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 163 167 <span type="species:ncbi:9925">goat</span>
For detection, goat anti-rabbit AlexaFluor 555 (1:500), goat anti-rat AlexaFluor 555 (1:500), goat anti-mouse AlexaFluor 488 (1:600, all from Molecular Probes) or goat FITC-conjugated anti-HRP (1:100, Jackson Immunoresearch) were used. In selected experiments an additional step with the UV fluorescent dye Hoechst 33258 (1:50000, Molecular Probes) for the nuclei labeling was performed.
###end p 85
###begin title 86
Immunocytochemistry
###end title 86
###begin p 87
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Menegon1">[37]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003579-Ciana1">[11]</xref>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 380 383 <span type="species:ncbi:10116">rat</span>
###xml 402 407 <span type="species:ncbi:10090">mouse</span>
###xml 444 449 <span type="species:ncbi:10090">mouse</span>
###xml 475 480 <span type="species:ncbi:10090">mouse</span>
###xml 528 533 <span type="species:ncbi:10090">mouse</span>
###xml 629 633 <span type="species:ncbi:9925">goat</span>
###xml 639 645 <span type="species:ncbi:9986">rabbit</span>
###xml 650 654 <span type="species:ncbi:9925">goat</span>
###xml 660 665 <span type="species:ncbi:10090">mouse</span>
Immunofluorescence analysis of cortical cultures was performed as previously described [37]. Double immunostaining was performed incubating fixed cultures with anti-GPR17 polyclonal antibody (1:150, 2.5 h at room temperature) [11] and one of the following primary antibodies: mouse anti-beta-Tubulin-III (beta-TubIII; 1:100), mouse anti-nestin (1:100), mouse anti-CNPase (1:100), rat anti-MBP (1:200), mouse anti-O4 (1:100, all from Chemicon), mouse anti-NG2 (1:200, Abcam), mouse anti-MAP2 (1:500, Immunological Sciences), and mouse anti-GFAP (1:500, Cell Signalling). Cells were then incubated for 1 h at RT with the secondary goat anti-rabbit and goat anti-mouse antibodies, conjugated to AlexaFluor 488 or AlexaFluor 555 (1:600, Molecular Probes). Coverslips were mounted with Fluorescent mounting medium (Dako), and analyzed by using an inverted fluorescence microscope (200 M; Zeiss) equipped with a CCD camera (AxioCam HRm; Zeiss), connected to a PC equipped with the Axiovision software (Zeiss).
###end p 87
###begin title 88
Propidium Iodide (PI) staining
###end title 88
###begin p 89
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
To evaluate the viability of in vitro cell cultures, after pharmacological treatments, cultures were loaded with 20 microM PI for 10 min. Under these conditions, PI can only enter cells with damaged permeabilized membrane and cannot label nuclei of intact viable cells. Cultures were then fixed with 4% paraformaldehyde plus 4% sucrose, and loaded with the nuclear dye Hoechst 33258. Nuclei were analyzed and counted using a fluorescence microscope (Zeiss). Since Hoechst 33258 gives a blue colour to nuclei under UV light, cells that remained alive during the pharmacological treatments showed blue nuclei with rounded appearance; conversely, cells that underwent cell death showed a red colour due to the incorporation of both dyes and were classified as dead. Data are presented as percentage of propidium iodide-positive nuclei over Hoechst 33258-labeled nuclei.
###end p 89
###begin title 90
Data analysis
###end title 90
###begin p 91
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 150 152 146 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
For [35S]GTPgammaS binding data analysis and graphic presentation, a non-linear multipurpose curve-fitting program Graph-Pad Prism was used and the EC50 values were derived. Data are reported as mean+/-SEM of three different experiments (performed in duplicate).
###end p 91
###begin p 92
For MRI studies, data on progression of ischemic damage over time were evaluated by ANOVA for repeated measures. For each animal, the ischemic area at 2 h after ischemia induction was set to 100%, and the extension of the ischemic area at all other time points was proportionally calculated, thus providing an internal control of ischemia development. Then, variations of ischemic volumes between animals and groups were compared. Six animals/group were used. Data are expressed as mean values+/-s.em. P values </=0.05 were considered statistically significant.
###end p 92
###begin p 93
Quantifications of immunoreactive cells were performed by fluorescence microscopy blindly in coronal sections of three intact and three lesioned hemispheres. Cells were counted using a 20x objective on an inverted fluorescence microscope (200 M; Zeiss). Depending on the experiment and on the parameters to be estimated, at least 700 cells/condition were counted.
###end p 93
###begin title 94
Ethical declaration
###end title 94
###begin p 95
This study on animals has been approved by the Council of the Department of Pharmacological Sciences of the University of Milan, Italy, which is legally entitled for the use of animals for scientific proposes (D.M. of Italian Ministry of Health, Authorization # 124/2003 of 13/10/2003 and #143/2004 of 13/12/2004), which is, in turn, based on the D.L. of 27 January 1992 nr. 116. Implementation of European Union Directive nr. 86/609/CEE regarding the Protection of animals used for experimental and other scientific purposes.
###end p 95
###begin title 96
Supporting Information
###end title 96
###begin p 97
###xml 42 48 <span type="species:ncbi:10090">murine</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
Endogenous and heterologous expression of murine GPR17 (A) RT-PCR analysis of GPR17 in various mouse tissues. Specific transcripts are found in brain and, to a lower extent, in kidney, heart and skeletal muscle. No detectable expression is found in liver and lung. Amplification of beta-actin is shown as an internal reaction control. (B) 1321N1 human astrocytoma cells were heterologously transfected with either pcDNA3.1 empty vector or pcDNA3.1-Gpr17m, as indicated. RT-PCR analysis shows the presence of the receptor transcript at the expected length of 1022 bp in the lane corresponding to the Gpr17 transfected cells. No amplification products are detected in the absence of retro-transcription (indicated as -) or in cells transfected with the empty vector. (C) Fluorescence immunocytochemistry in 1321N1 cells shows that no expression of GPR17 can be detected in cells transfected with pcDNA3.1 empty vector incubated with the anti-GPR17 antibody (left panel), whereas a specific signal (green fluorescence) is present in cells transfected with pcDNA3.1-Gpr17m (center panel). To confirm the specificity of the signal, preincubation of the antibody with its neutralizing peptide abolishes GPR17 positivity in these cells (right panel). Scale bar: 30 microm.
###end p 97
###begin p 98
(0.49 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 216 227 <span type="species:ncbi:64105|species:ncbi:43770">c. striatum</span>
Association of GPR17+ cells with myelinating fibers. Double staining fluorescence microscopy image of GPR17+ ramified precursor cells (green fluorescence) and MBP+ myelinating tracts (red fluorescence) in the intact c. striatum. Immature GPR17+ precursors cells do not co-express MBP but are often found physically associated to or inside MBP+ myelinating fibers. These cells may represent a source of pre-oligodendrocytes able to turn into myelinating cells when necessary; alternatively, they could play a role in the local trophic control of myelination. Scale bar: 50 microm.
###end p 100
###begin p 101
(0.54 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 143 146 <span type="species:ncbi:10116">rat</span>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 456 461 <span type="species:ncbi:9606">human</span>
###xml 463 466 <span type="species:ncbi:10116">rat</span>
###xml 471 476 <span type="species:ncbi:10090">mouse</span>
###xml 866 871 <span type="species:ncbi:9606">human</span>
###xml 873 878 <span type="species:ncbi:10090">mouse</span>
###xml 883 886 <span type="species:ncbi:10116">rat</span>
Potential Olig2 binding sites upstream of the GPR17 coding sequence. Sequence alignments of 8 Kb upstream to the coding sequence of the human, rat and mouse GPR17 gene have been performed using BLAST program from NCBI (). Identification of responsive sites for Neurogenin and NeuroD family of transcription factors (such as Atoh1, Neurod1, Neurod2, Neurod4, Neurod6, Neurog1, Neurog2, Neurog3, TGF12 and TGF3 and Olig2) in the upstream sequences of GPR17 (human, rat and mouse) was performed by using MatInspector Release Professional 7.7.3 software from Genomatix. GPR17 upstream sequences globally display a low homology rate in the three species, except in six regions which are highly homologous and conserved among phylogenesis. Here we show only the two of them (E-Box 1 and E-Box 2) in which the E-Box element, potentially able to bind Olig2, is identical in human, mouse and rat.
###end p 103
###begin p 104
(0.36 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
The authors are grateful to Dr. Stefania Ceruti, University of Milan for useful discussion and critical advice. and to Dr. Steven Condliffe, University of Milan, for help in the single cell PCR analysis. Cangrelor was a kind gift from The Medicines Company, Parsippany, NJ, USA.
###end p 106
###begin title 107
References
###end title 107
###begin article-title 108
Cellular distribution and functions of P2 receptor subtypes in different systems.
###end article-title 108
###begin article-title 109
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
###end article-title 109
###begin article-title 110
The discovery of the leukotrienes.
###end article-title 110
###begin article-title 111
Leukotrienes in asthma.
###end article-title 111
###begin article-title 112
International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.
###end article-title 112
###begin article-title 113
CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation.
###end article-title 113
###begin article-title 114
###xml 116 119 <span type="species:ncbi:10116">rat</span>
P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia.
###end article-title 114
###begin article-title 115
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Production of leukotrienes in a model of focal cerebral ischaemia in the rat.
###end article-title 115
###begin article-title 116
###xml 54 57 <span type="species:ncbi:10116">rat</span>
ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.
###end article-title 116
###begin article-title 117
###xml 91 96 <span type="species:ncbi:9606">human</span>
A novel orphan G protein-coupled receptor primarily expressed in the brain is localized on human chromosomal band 2q21.
###end article-title 117
###begin article-title 118
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.
###end article-title 118
###begin article-title 119
###xml 43 48 <span type="species:ncbi:9606">human</span>
Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state.
###end article-title 119
###begin article-title 120
###xml 40 45 <span type="species:ncbi:9606">human</span>
Pharmacological characterization of the human P2Y13 receptor.
###end article-title 120
###begin article-title 121
###xml 33 38 <span type="species:ncbi:9606">human</span>
Functional characterization of a human receptor for neuropeptide FF and related peptides.
###end article-title 121
###begin article-title 122
###xml 66 69 <span type="species:ncbi:10116">rat</span>
Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor.
###end article-title 122
###begin article-title 123
Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair.
###end article-title 123
###begin article-title 124
NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors?
###end article-title 124
###begin article-title 125
Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis.
###end article-title 125
###begin article-title 126
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.
###end article-title 126
###begin article-title 127
Astrocytes give rise to new neurons in the adult mammalian hippocampus.
###end article-title 127
###begin article-title 128
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain.
###end article-title 128
###begin article-title 129
A unified hypothesis on the lineage of neural stem cells.
###end article-title 129
###begin article-title 130
The molecular orchestra of the migration of oligodendrocyte precursors during development.
###end article-title 130
###begin article-title 131
###xml 176 179 <span type="species:ncbi:10116">rat</span>
The inducible 70,000 molecular/weight heat shock protein is expressed in the degenerating dentate hilus and piriform cortex after systemic administration of kainic acid in the rat.
###end article-title 131
###begin article-title 132
Regeneration of the central nervous system using endogenous repair mechanisms.
###end article-title 132
###begin article-title 133
The experimental use of antisense oligonucleotides: a guide for the perplexed.
###end article-title 133
###begin article-title 134
Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo.
###end article-title 134
###begin article-title 135
Ten years of antisense inhibition of brain G-protein-coupled receptor function.
###end article-title 135
###begin article-title 136
bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS.
###end article-title 136
###begin article-title 137
Desensitization of G protein-coupled receptors and neuronal functions.
###end article-title 137
###begin article-title 138
Inflammation and glial responses in ischemic brain lesions.
###end article-title 138
###begin article-title 139
Differential phosphorylation of syntaxin and synaptosome-associated protein of 25 kDa (SNAP-25) isoforms.
###end article-title 139
###begin article-title 140
###xml 144 147 <span type="species:ncbi:10116">rat</span>
Focal cerebral ischemia induces increased myelin basic protein and growth-associated protein-43 gene transcription in peri-infarct areas in the rat brain.
###end article-title 140
###begin article-title 141
Glutamate-mediated overexpression of CD38 in astrocytes cultured with neurones.
###end article-title 141
###begin article-title 142
###xml 60 64 <span type="species:ncbi:10116">rats</span>
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage.
###end article-title 142
###begin article-title 143
###xml 47 51 <span type="species:ncbi:10116">rats</span>
New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study.
###end article-title 143
###begin article-title 144
Spatial and temporal regulation of Ca2+/calmodulin-dependent protein kinase II activity in developing neurons.
###end article-title 144
###begin p 145
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: MLT, PC, CV, CM and MPA are inventors in the Italian Patent Application #2004A002007 on "Modulatori del recettore GPR17 e loro impieghi terapeutici" submitted on October 21, 2004.
###end p 145
###begin p 146
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This project was supported by the Italian Ministry of Education, Progetti FIRB2003 #RBNE03YA3L_009 and COFIN-MIUR 2006059022 "PURINOCEPTORS AND NEUROPROTECTION" to MPA, and by the CARIPLO Foundation Grant 2006/0882 "GENOMICS AND PROTEOMICS OF G PROTEIN-COUPLED RECEPTORS: NOVEL TARGETS FOR THE DIAGNOSIS AND PREVENTION OF HUMAN DISEASES" to prof. Francesco Clementi, University of Milan, by the Progetto Alfieri, Fondazione CRT to AB. GV has been supported by a fellowship by the Centro Neurolesi "Bonino-Pulejo", Messina, Italy.
###end p 146

